Sunderland
Sunderland v. PharmaCare U.S., Inc.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 11 LINDA SUNDERLAND and Case No.: 3:23-cv-01318-JES-AHG
BENJAMIN BINDER,
ORDER GRANTING JOINT individually and on behalf of all others
MOTION TO EXTEND DEADLINE
similarly situated,
TO CONTACT THE COURT
Plaintiffs, REGARDING DISCOVERY
DISPUTE
v.
PHARMACARE U.S., INC., et al., [ECF No. 47] Defendants. 19 Before the Court is the parties’ joint motion to extend the deadline to raise discovery disputes with the Court. ECF No. 47. Under the Court’s 45-Day Rule (see AHG.Chmb.R. at 2–3), the parties would have been required to bring any discovery dispute regarding NIS Labs’s responses to Defendant’s subpoena duces tecum to the Court’s attention by April 27, 2024. The parties seek an order from the Court extending the deadline slightly. Parties seeking to continue deadlines must demonstrate good cause. Chmb.R. at 2 (stating that any request for continuance requires “[a] showing of good…